Drug Detail:Imiquimod topical (Imiquimod topical [ i-mi-kwi-mod-top-ik-al ])
Drug Class: Topical anti-infectives Topical antineoplastics
Imiquimod Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the use of imiquimod during breastfeeding. However, because the drug is used on a limited surface area and poorly absorbed into the maternal circulation, effects on the infant are unlikely. If imiquimod is required by the mother, it is not a reason to discontinue breastfeeding. Do not apply imiquimod to the breast or nipple and ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Imiquimod
CAS Registry Number
99011-02-6
Drug Class
Breast Feeding
Lactation
Adjuvants, Immunologic
Antineoplastic Agents
Interferon Inducers
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification